Evidence map›Paper›PMID 28903042›Full record

ArticleCell reports2017

Distortion of the Actin A-Triad Results in Contractile Disinhibition and Cardiomyopathy.

Meera C Viswanathan, William Schmidt, Michael J Rynkiewicz, Karuna Agarwal, Jian Gao, Joseph Katz, William Lehman, Anthony Cammarato

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cardiomyocyte Dysfunction in Inherited Cardiomyopathies.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Review
  16. Article
  17. Review
  18. KBTBD13 and the ever-expanding sarcomeric universe.The Journal of clinical investigation · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Meera C ViswanathanDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
William SchmidtDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Michael J RynkiewiczDepartment of Physiology and Biophysics, Boston University School of Medicine, Boston, MA 02118, USA.
Karuna AgarwalDepartment of Mechanical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
Jian GaoDepartment of Mechanical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
Joseph KatzDepartment of Mechanical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
William LehmanDepartment of Physiology and Biophysics, Boston University School of Medicine, Boston, MA 02118, USA.
Anthony CammaratoDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: acammar3@jhmi.edu.
Johns Hopkins University · USBoston University · USJohns Hopkins Medicine · US

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
PATHOGENESIS AND IN VIVO SUPPRESSION OF THIN FILAMENT-BASED CARDIOMYOPATHIESR01HL124091 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Anthony Cammarato · 2015 to 2026
$4.3M
Thin Filaments and Muscle RegulationR37HL036153 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LEHMAN, WILLIAM J · 2008 to 2017
$4.1M
Pathogenesis and in vivo suppression of thin filament based cardiomyopathiesR56HL124091 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CAMMARATO, ANTHONY · 2014 to 2014
$383k
NHLBI NIH HHS R01 HL124091NHLBI NIH HHS R37 HL036153NHLBI NIH HHS R56 HL124091NHLBI NIH HHS T32 HL007227
6 · The paper itself

Abstract

Striated muscle contraction is regulated by the movement of tropomyosin over the thin filament surface, which blocks or exposes myosin binding sites on actin. Findings suggest that electrostatic contacts, particularly those between K326, K328, and R147 on actin and tropomyosin, establish an energetically favorable F-actin-tropomyosin configuration, with tropomyosin positioned in a location that impedes actomyosin associations and promotes relaxation. Here, we provide data that directly support a vital role for these actin residues, termed the A-triad, in tropomyosin positioning in intact functioning muscle. By examining the effects of an A295S α-cardiac actin hypertrophic cardiomyopathy-causing mutation, over a range of increasingly complex in silico, in vitro, and in vivo Drosophila muscle models, we propose that subtle A-triad-tropomyosin perturbation can destabilize thin filament regulation, which leads to hypercontractility and triggers disease. Our efforts increase understanding of basic thin filament biology and help unravel the mechanistic basis of a complex cardiac disorder.

Indexed as

Actin CytoskeletonActinsActomyosinAmino Acid SequenceAnimalsAnimals, Genetically ModifiedBiomechanical PhenomenaCalciumCardiac OutputCardiomyopathiesConserved SequenceDiastoleDrosophila melanogasterMuscle ContractionMuscle, SkeletalMutationActinsActomyosinCalciumTropomyosincardiomyopathycomputational modelingdiastolic dysfunctionDrosophilahypertrophic cardiomyopathyindirect flight musclemuscle regulationsarcomerethin filamenttropomyosintroponin

Identifiers

PMID28903042
PMCPMC5902318
OpenAlexW2754577872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.